09:09In Silico Clinical Trials for Cardiovascular Disease
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Clinical Trials
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 19, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
S Percy Ivy1, Jeffrey S Abrams1
1Investigational Drug Branch, Cancer Therapy Evaluation Program (SPI), Cancer Therapy Evaluation Program (JSA), Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
No abstract available in PubMed .